The Bid & Ask

Quotations, Dispatches, and the Daily Tape

Friday, August 14, 2026

Subject of the day

PRGO

Concerning the House

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. The company also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products. It sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. The company also offers contract manufacturing services. It sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Ireland · www.perrigo.com

The Long Run

FY 2014–2025 · 11 years

LineLatestCAGRTrend
Revenue$4.66B+19.7%
Gross profit$1.49B+0.3%
Operating income$151.90M-15.2%
Net income-$171.80M-30.9%
Cash from ops$405.50M-2.3%
Quotation

$12.83

+0.14 (+1.1%)

52w hi$23.06
52w lo$9.02
Vol2.53M
As ofAug 13
The Verdict

Hold

Our score -0.33

Short-0.26
Medium-0.25
Long-0.65

computed 2026-08-13

By the Numbers

Perrigo Company plc

Healthcare · Drug Manufacturers - Specialty & Generic

Market cap$1.78B
Enterprise value$4.84B
Trailing P/E
Forward P/E5.35x
EV / EBITDA7.86x
P / S (ttm)0.43x
Profit margin-41.9%
Return on equity-48.7%
Revenue growth-3.2%
Earnings growth
Debt / equity138.18
Risk Metrics
Beta vs SPX0.84
Corr SPX0.30
Annual vol46.4%
Annual ret-28.0%
Sharpe-0.60
Max DD-68.6%

Window: 504 trading days (504 obs)

Layer Breakdown
LayerRawContribution
Fundamental-0.13
Sector+0.12
Technical-0.16
Earnings+0.00
Sentiment+0.00

macro × 1.00 · 2026-08-13

Recent Sessions
DateOpenHighLowCloseVol
Aug 13$12.80$13.07$12.51$12.832.53M
Aug 12$12.58$12.76$12.16$12.692.36M
Aug 11$12.53$12.95$12.42$12.852.27M
Aug 10$12.63$12.78$12.36$12.642.01M
Aug 7$12.73$13.04$12.42$12.842.11M